据报道，KKR 将 Bridgebio Pharma 股票出售的近 60% 分配给了五家公司

KKR 将其 BridgeBio Pharma (BBIO) 二次股票出售的近 60% 分配给五位主要投资者。这次 500 万股的发行，每股定价为 28 美元，为 KKR 带来了超过 3.87 亿美元的总收入。需求大大超过供应，分配更倾向于长期投资和专注于医疗保健的基金

Nearly 60% of KKR’s (KKR) sale of BridgeBio Pharma (BBIO) shares was allocated to the five biggest investors who took part in the offering, Bloomberg reported on Friday, citing people familiar with the matter. Palo Alto, California-based BridgeBio (BBIO) on Thursday announced the secondary offering of 5M shares by KKR Genetic Disorder L.P., with Wi...